Fapon Biopharma to Present Next-Generation CD3/TCR VHH TCE Platform at 19th Annual European Life Sciences CEO Forum

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Fapon-Biopharma

More Like This

PR Newswire associated0

Fapon Highlights Innovative IVD Total Solutions and Localization Services at MEDICA 2024

PR Newswire associated0

Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid Tumors

PR Newswire associated0

Fapon at MEDICA 2025: AI-Driven Breakthroughs in Diagnostic Solutions, Featuring Advanced AD Blood Testing

Business Wire logo

Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti-CD40 mAb) Phase I Trial at ESMO 2023

ACCESSWIRE associated3

New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine

ACCESSWIRE associated1

HanchorBio to Present at the ESMO Immuno-Oncology 2023 Annual Congress

Business Wire logo

Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies

WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager